Global RNA Analysis/ Transcriptomics Market Report 2024

RNA Analysis Transcriptomics Global Market Report 2023 – By Product (Reagents/Consumables, Instruments, Software), By Technology (Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference), By Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
RNA Analysis/ Transcriptomics Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Transcriptomics/RNA analysis is a study of the transcriptome under specific circumstances, environment, or in a specific cell using high-throughput methods.

The main types of products in the RNA analysis/ transcriptomics market are reagents/consumables, instruments, and software. It is implemented in various areas including clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference. Major technology involved in RNA analysis/ transcriptomics are microarrays, sequencing, polymerase chain reaction RNA interference. RNA analysis is used in clinical diagnosis to detect different RNA species, and pathogen RNA splice variants among others useful in the diagnosis of diseases.

The global RNA analysis or transcriptomics market is segmented -

1) By Product: Reagents/Consumables, Instruments, Software

2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference

3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference

The global RNA analysis/ transcriptomics market size grew from $5.96 billion in 2022 to $6.76 billion in 2023 at a compound annual growth rate (CAGR) of 13.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of RNA analysis/ transcriptomics is expected to grow to $11.33 billion in 2027 at a CAGR of 13.8%.

The increasing demand for personalized medicine is expected to drive the growth of the RNA analysis/ transcriptomics market in the coming years. Personalized medicine refers to the customizing of medical treatment to each patient's unique characteristics.  If scientists can implement the necessary practices and processes for personalized clinical care, RNA-Seq will be well-positioned to handle the massive clinical workload.  According to the Personalized Medicine Report 2020 published by the Personalized Medicine Coalition (PMC), the number of personalized medicines in the market more than doubled between 2016 and 2020 in the USA. Therefore, the growing demand for personalized medicines propels the growth of the RNA analysis market.

Major players in the RNA analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, and Biomereiux SA.

Technological advancements and innovations in RNA analysis are an emerging trend in the RNA analysis/ transcriptomics market. Technologies such as next-generation sequencing (NGS) and RNA interference (RNAi) improved precision and accuracy, which help researchers analyze the transcriptional activity. For instance, Next-generation sequencing developed by Illumina is successfully used in fragmenting DNA/RNA into multiple pieces, adding adapters, sequencing the libraries, and reassembling them to form a genomic sequence.

In October 2020, 10x Genomics, a startup based in the USA acquired Cartana for an amount of $41.2 million. The acquisition of Cartana is expected to strengthen its approach to developing technologically advanced products. Cartana is a Sweden-based biotechnology player involved in developing in situ RNA analysis technology.

North America was the largest region in the RNA analysis/transcriptomics market in 2022. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the RNA analysis/ transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The RNA analysis/ transcriptomics market includes revenues earned by entities by providing services such as Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Microarray Analysis, Sanger Sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The RNA analysis/ transcriptomics market research report is one of a series of new reports from The Business Research Company that provides RNA analysis/ transcriptomics market statistics, including RNA analysis/ transcriptomics industry global market size, regional shares, competitors with a RNA analysis/ transcriptomics market share, detailed RNA analysis/ transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA analysis/ transcriptomics industry. This RNA analysis/ transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. RNA Analysis/ Transcriptomics Market Characteristics

    3. RNA Analysis/ Transcriptomics Market Trends And Strategies

    4. RNA Analysis/ Transcriptomics Market – Macro Economic Scenario

    4.1 COVID-19 Impact On RNA Analysis/ Transcriptomics Market

    4.2 Ukraine-Russia War Impact On RNA Analysis/ Transcriptomics Market

    4.3 Impact Of High Inflation On RNA Analysis/ Transcriptomics Market

    5. RNA Analysis/ Transcriptomics Market Size And Growth

    5.1. Global RNA Analysis/ Transcriptomics Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global RNA Analysis/ Transcriptomics Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. RNA Analysis/ Transcriptomics Market Segmentation

    6.1. Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Reagents/Consumables

    Instruments

    Software

    Services

    6.2. Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Microarrays

    Sequencing

    Polymerase Chain Reaction

    RNA Interference 

    6.3. Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Clinical Diagnostics

    Drug Discovery

    Toxicogenomics

    Comparative Transcriptomics 

    7. RNA Analysis/ Transcriptomics Market Regional And Country Analysis

    7.1. Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific RNA Analysis/ Transcriptomics Market  

    8.1. Asia-Pacific RNA Analysis/ Transcriptomics Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China RNA Analysis/ Transcriptomics Market  

    9.1. China RNA Analysis/ Transcriptomics Market Overview  

    9.2. China RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India RNA Analysis/ Transcriptomics Market  

    10.1. India RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan RNA Analysis/ Transcriptomics Market  

    11.1. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia RNA Analysis/ Transcriptomics Market  

    12.1. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia RNA Analysis/ Transcriptomics Market  

    13.1. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea RNA Analysis/ Transcriptomics Market  

    14.1. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe RNA Analysis/ Transcriptomics Market  

    15.1. Western Europe RNA Analysis/ Transcriptomics Market Overview

    15.2. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK RNA Analysis/ Transcriptomics Market  

    16.1. UK RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany RNA Analysis/ Transcriptomics Market  

    17.1. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France RNA Analysis/ Transcriptomics Market  

    18.3. France RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe RNA Analysis/ Transcriptomics Market  

    19.1. Eastern Europe RNA Analysis/ Transcriptomics Market Overview

    19.2. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia RNA Analysis/ Transcriptomics Market  

    20.1. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America RNA Analysis/ Transcriptomics Market  

    21.1. North America RNA Analysis/ Transcriptomics Market Overview

    21.2. North America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA RNA Analysis/ Transcriptomics Market  

    22.1. USA RNA Analysis/ Transcriptomics Market Overview

    22.2. USA RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America RNA Analysis/ Transcriptomics Market  

    23.1. South America RNA Analysis/ Transcriptomics Market Overview

    23.2. South America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil RNA Analysis/ Transcriptomics Market  

    24.1. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East RNA Analysis/ Transcriptomics Market  

    25.1. Middle East RNA Analysis/ Transcriptomics Market Overview

    25.2. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa RNA Analysis/ Transcriptomics Market  

    26.1. Africa RNA Analysis/ Transcriptomics Market Overview

    26.2. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. RNA Analysis/ Transcriptomics Market Competitive Landscape And Company Profiles

    27.1. RNA Analysis/ Transcriptomics Market Competitive Landscape

    27.2. RNA Analysis/ Transcriptomics Market Company Profiles

    27.2.1. Affymetrix Inc. 

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Agilent Technologies Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bio-Rad Laboratories Inc. 

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GE Healthcare 

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Illumina Inc. 

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market

    29. RNA Analysis/ Transcriptomics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Affymetrix Inc.  Financial Performance
  • Table 28: Agilent Technologies Inc. Financial Performance
  • Table 29: Bio-Rad Laboratories Inc.  Financial Performance
  • Table 30: GE Healthcare  Financial Performance
  • Table 31: Illumina Inc.  Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Affymetrix Inc.  Financial Performance
  • Figure 28: Agilent Technologies Inc. Financial Performance
  • Figure 29: Bio-Rad Laboratories Inc.  Financial Performance
  • Figure 30: GE Healthcare  Financial Performance
  • Figure 31: Illumina Inc.  Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report